Form D · Biotechnology
Abcuro, Inc.
Newton, MA · CIK 0001692147
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- $39.4M Offering amount: $177M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | $39,383,108 | No comparison | 23 | SEC filing |
| Feb 19, 2025 | Initial | $79,999,955 | No comparison | 21 | SEC filing |
| Aug 25, 2023 | Initial | $120,141,750 | No comparison | 21 | SEC filing |
| Jan 22, 2021 | Amendment | $15,499,981 | $7,899,991vs Jul 6, 2020 | 15 | SEC filing |
| Jul 6, 2020 | Initial | $7,599,990 | No comparison | 7 | SEC filing |
| Nov 21, 2018 | Initial | $8,000,000 | No comparison | 3 | SEC filing |
| Dec 13, 2016 | Initial | $2,250,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594134
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan Berry | Director |
| Sarah Boyce | Director |
| David De Graaf | Director, Executive |
| Darlene Deptula Hicks | Director |
| Michael Dybbs | Director |
| John Edwards | Director |
| Ming Fang | Director |
| Stefano Gulla | Executive |
| Jason Hafler | Director |
| Ron Hunt | Director |
| Tomer Kariv | Director |
| Julius Knowles | Director |
| Daniel Mansuri | Director |
| John Alexander Martin | Director, Executive |
| Donald Mc Carthy | Director |
| Robert Millman | Director |
| Richard Motschwiller | Executive |
| Michele Park | Director |
| Mark Pruzanski | Director |
| Iyona Rajkomar | Director |
| Rajeev Shah | Director |
| K. Evan Thompson | Director, Executive |
| Evan Thompson | Executive |
| Nalan Utku | Director |
| Yajun Xu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
55 Chapel St Suite 200
Newton, MA, 02458
Phone: (617) 714-9759
Newton, MA, 02458
Phone: (617) 714-9759